“…The formulation of nanocrystals, polymeric nanoparticles, lipid nanoparticles, nanofibers, micelles, and carbon nanoparticles has been explored. The reduction of particle size to the nanometer scale increases the surface area giving the system differential properties, such as improved apparent saturation solubility (as described in the Ostwald–Freundlich equation), increased dissolution rates (Noyes–Whitney equation), and especially in the case of systems, such as nanocrystals, increased bioadhesive to surface membranes (due to the increase in the number of contact points) [ 17 , 23 , 24 , 25 , 26 ]. In particular, nanocrystals, defined as submicron particles composed of 100% stabilized drugs in a crystalline state, emerge as one of the most promising approaches for improving the in vivo performance of orally administered class II drugs [ 27 ].…”